-- Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini,...
REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures RNA sequencing and circulating tumor...
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data...
SAN FRANCISCO, CA / ACCESS Newswire / August 15, 2025 / Ambience Healthcare, a leading AI platform for documentation, coding,...
CHARLOTTESVILLE, Va., Aug. 14, 2025 /PRNewswire/ -- RIVANNA®, developers of world-first imaging-based medical technologies, was recently awarded grant funding valued...
Executive Strategist to Lead Global Brand, Market Growth, and Cross-Vertical Commercialization for Quantum Detection Pioneer STUART, Fla., Aug. 14, 2025...
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the...
DELRAY BEACH, Fla., Aug. 14, 2025 /PRNewswire/ -- The global Enterprise Imaging IT Market, valued at US$2.08 billion in 2024, stood...
Built to Connect Patients and Providers, the HFSA Database is Now Open for Searching and Submissions WASHINGTON, Aug. 14, 2025...
Collaboration enhances patient outcomes, improves provider efficiency, and streamlines workflow diagnostics WESTLAKE, Texas and MIDDLEBURY, Conn., Aug. 14, 2025 /PRNewswire/ -- AvodahMed, a leader in AI-powered clinical documentation, and Pulse4Pulse (P4P), a pioneer...
New York State Department of Health (NYSDOH) clinical laboratory permit facilitates Q3 2025 launch of the FDA-cleared PreClara™ Ratio (sFlt-1/PlGF)...
PLAINVIEW, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified...
10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked...
REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS)...
Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH)Results build...
Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and...
CNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations CNSide® may...
HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Testing technologies play a pivotal role in disease diagnosis. Currently, flow cytometers are widely...
AI-powered delivery date prediction model shows high accuracy and improved performance over time, with promise for global maternal health impact...
LISLE, Ill., Aug. 13, 2025 /PRNewswire/ -- Forum Health, a leading nationwide provider of functional and integrative medicine, today announced the...